The molecular underpinnings by which traumatic brain injury increases Alzheimer’s disease risk

Findings indicate BAG3 modulation after traumatic brain injury may mitigate tau buildup and cognitive deficits, presenting a target for Alzheimer’s prevention.

Teva, Sanofi conclude collaboration deal for anti TL1A therapy

Share this article TEV ‘574 is under assessment in Phase IIb clinical studies to treat ulcerative colitis and Crohn’s disease. Credit: sdecorated / Shutterstock.com. Teva

December 1, 2023

BlossomHill secures $100m funds to advance cancer programmes

Share this article The company plans to utilise the proceeds to progress its multiple in-house discovery and development programmes. Credit: Bullstar / Shutterstock.com. BlossomHill Therapeutics

March 1, 2024

Bill Nye, Science Guy, speaks out on ataxia

Bill Nye the Science Guy is temporarily rebranding. For now, he’s “Bill Nye the Ataxia Advocate Guy,” as he aims to bring awareness to a

October 10, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.